Format

Send to

Choose Destination
See comment in PubMed Commons below
Int J Mol Sci. 2012;13(4):4831-8. doi: 10.3390/ijms13044831. Epub 2012 Apr 16.

Curcumin enhances cytotoxic effects of bortezomib in human multiple myeloma H929 cells: potential roles of NF-κB/JNK.

Author information

  • 1Department of Hematology, State Center of Bone Marrow Transplantation, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China; E-Mail: zhishui2004@163.com.

Abstract

Combined curcumin and PS-341 treatment has been reported to enhance cytotoxicity and minimize adverse effects through ERK and p38MAPK mechanisms in human multiple myeloma cells. However, whether JNK plays similar role in this process remains unclear. In the present study, we found combined treatment altered NF-κB p65 expressions and distributions in multiple myeloma H929 cells. Western blot analysis showed combined treatment inactivated NF-κB while activated JNK signaling. Pre-treatment with JNK inhibitor SP600125 could attenuate NF-κB inactivation and restored H929 cells' survival. These results suggested that curcumin might enhance the cytotoxicity of PS-341 by interacting with NF-κB, at least in part, through JNK mechanism.

KEYWORDS:

JNK; NF-κB; PS-341; curcumin; multiple myeloma

PMID:
22606012
PMCID:
PMC3344248
DOI:
10.3390/ijms13044831
[PubMed - indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Multidisciplinary Digital Publishing Institute (MDPI) Icon for PubMed Central
    Loading ...
    Support Center